Clinical trial · Observational
Lung Cancer Surgery in Sarcopenia Patients With Old Age
Association of Preoperative Sarcopenia on Postoperative Outcomes After Lung Cancer Surgery: Prospective Observational Study
NCT05346185CI-TRIAL-00100511LUCAS-PENactive not recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The presence of sarcopenia before lung resection surgery might be an important factor of short-term and long-term prognosis in lung cancer patients. Through this study, investigators plan to demonstrate evidence whether sarcopenia is a useful clinical biomarker for risk stratification in elderly patients undergoing lung cancer surgery.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
| Sarcopenia | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- overall survival
- timeFrame
- 5 years after the day of lung cancer surgery
- description
- survival status during the follow-up after the lung cancer surgery
Secondary outcomes (10)
- measure
- recurrence free survival
- timeFrame
- up to 5 years after the day of lung cancer surgery
- description
- any recurrence or death during the follow-up after the lung cancer surgery
- measure
- non-cancer related mortality
- timeFrame
- up to 5 years after the day of lung cancer surgery
- description
- any death not related to lung cancer during the follow-up after the lung cancer surgery
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Patients planning to perform curative surgery for confirmed lung cancer and pulmonary nodules suspected for lung cancer * Patients or legal representatives who could understand and write written consent prior to the initiation of the clinical trial and are able to comply with the requirements for the clinical trial Exclusion Criteria: * Patients with treatment history for lung cancer or other solid cancer within 5 years (except patients with adenocarcinoma in situ for lung cancer) * Patients who need simultaneous surgery with lung caner surgery for other accompanying diseases * Patients who are not eligible to participate in the study judged by the researcher
References
Publications (1)
- DERIVEDWoo HS, Na KJ, Yun T, Park JH, Na B, Park S, Lee HJ, Kang CH, Kim YT, Park IK. Impact of sarcopenia on early surgical outcomes in elderly patients following lung cancer surgery: a prospective cohort study. J Thorac Dis. 2025 Oct 31;17(10):7838-7852. doi: 10.21037/jtd-2025-1375. Epub 2025 Oct 29. PMID 41229782